Jump to main content.


Protection of Stratospheric Ozone

 [Federal Register: October 14, 1994] 
	  ENVIRONMENTAL PROTECTION AGENCY
	  40 CFR Part 82 [FRL-5087-6]
     Protection of Stratospheric Ozone 

     AGENCY: Environmental 
	  Protection Agency. ACTION: Proposed rule. 
	  
	  SUMMARY: This document proposes to allocate potential production allowances 
	  to producers who have baseline allowances for the production of methyl bromide. 
	  These potential production allowances would be intended solely for the production 
	  of methyl bromide for export to Article 5 countries, as defined under Article 
	  5 of the Montreal Protocol on Substances that Deplete the Ozone Layer. In 
	  drafting the accelerated phaseout rule, which was published in the Federal 
	  Register on December 10, 1993, the Agency inadvertently omitted methyl bromide 
	  from the list of chemicals for which potential production allowances were 
	  granted. Today's action proposes an allocation of potential production allowances 
	  for all control periods beginning January 1, 1994, and ending before January 
	  1, 2001, equal to 10 percent of a company's baseline production allowances. 
	  The Agency may propose potential production allowances for methyl bromide 
	  for control periods after January 1, 2001, at a later date. 
	   DATES: Written comments on this proposed rule must be received on or 
		before November 14, 1994, unless a public hearing is requested. In the 
		case where a public hearing is requested, the public hearing will be scheduled 
		on October 31, 1994. Comments must then be received on or before 30 days 
		following the public hearing. Any party requesting a public hearing must 
		notify the contact person listed below by October 24, 1994. Inquiries 
		regarding a public hearing should be directed to the Stratospheric Ozone 
		Information Hotline at 1-800-296-1996. 
	   ADDRESSES: Comments on this proposed rulemaking should be submitted 
		in duplicate (two copies) to: Air Docket No. A-92-13, U.S. Environmental 
		Protection Agency, 401 M Street, SW., room M-1500, Washington, DC 20460.
		Materials relevant to this proposed rulemaking are contained in Docket 
		No. A-92-13. The Docket is located in room M-1500, First Floor, Waterside 
		Mall at the address above. The materials may be inspected from 8 a.m. 
		until 4 p.m. Monday through Friday. A reasonable fee may be charged by 
		EPA for copying the docket. 
	   FOR FURTHER INFORMATION CONTACT: Tom Land, Program Implementation Branch, 
		Stratospheric Protection Division, Office of Atmospheric Programs, Office 
		of Air and Radiation (6205J), 401 M Street, SW., Washington, DC 20460, 
		(202) 233-9185. The Stratospheric Ozone Hotline at 1-800-296-1996 can 
		also be contacted for further information. 
	   I. Background 
	   When Parties to the Montreal Protocol on Substances that Deplete the 
		Ozone Layer (the Protocol) first met in 1987, they agreed to allow additional 
		production of controlled substances for developing countries beyond the 
		levels being set for the developed countries. The United States, as well 
		as other Parties to the Protocol, recognized the need to continue to supply 
		controlled substances to developing countries during the period of scheduled 
		reductions and for a limited time after the phaseout of production of 
		controlled substances. In Article 2H of the Protocol, the Parties agreed 
		to allow production after the phaseout occurred. Under Article 5 of the 
		Protocol, developing countries are defined as Parties to the Protocol 
		consuming less than 0.3 kilograms per capita of class I, Group I and II 
		controlled substances. These Article 5 countries have limited resources 
		to adopt alternative technologies to replace the phased out controlled 
		substances. To ensure that such countries do not purchase the technologies 
		to produce controlled substances and otherwise bypass controls on controlled 
		substances, the Parties to the Protocol agreed to provide a set-aside 
		level of production for Article 5 countries. Article 5 countries must 
		ensure that these imported controlled substances are used to meet basic 
		domestic needs.
		The Environmental Protection Agency (EPA) implements a program domestically 
		that limits and monitors production and consumption of controlled substances, 
		including methyl bromide. Production for Article 5 countries in the United 
		States is monitored by allocating potential production allowances to those 
		companies that have baseline production allowances. Since 1989, EPA has 
		allocated potential production allowances equal to 10 percent of baseline 
		production allowances for specific controlled substances. Upon the complete 
		phaseout of a controlled substance, and until 10 years after the phaseout, 
		companies are allocated up to 15 percent of their production baseline 
		for export to Article 5 countries. EPA grants authorization to convert 
		potential production allowances to production allowances to producers 
		once they have exported to an Article 5 country. The July 30, 1992 Federal 
		Register document (57 FR 33754) as well as the December 10, 1993 Federal 
		Register document (58 FR 65018) explain these controls, as well as the 
		recordkeeping and reporting required for such transactions. The specific 
		provisions governing production for, and export to, Article 5 countries 
		are in Secs. 82.9 and 82.11. Appendix D of subpart A of 40 CFR part 82 
		contains a listing of Article 5 countries.<SUP>1 
	  
	   \1\EPA is drafting proposed amendments to the accelerated phaseout rule 
		that will make minor adjustments to the provisions for exports to Article 
		5 countries.
	  
	   II. Need To Allocate Methyl Bromide Production Allowances 
	   In the December 10, 1993 publication of the accelerated phaseout (58 
		FR 65018) adding methyl bromide to list of class I controlled substances, 
		the Agency inadvertently neglected to also allocate potential production 
		allowances for methyl bromide. At the time of proposal, the Agency focused 
		on the level of control of methyl bromide and its phaseout, but inadvertently 
		failed to propose additional production of methyl bromide for Article 
		5 countries. Due to this oversight, EPA is proposing through this Notice 
		to grant potential production allowances to methyl bromide producers equal 
		to 10 percent of their baseline allowances beginning in the current control 
		period (which began January 1, 1994). As with other controlled substances, 
		the 10 percent level of production for Article 5 countries would continue 
		until the effective date of the phaseout of production of the substance, 
		in this case, until January 1, 2001, for methyl bromide. Section 602(d) 
		of the CAA establishes the phaseout date for methyl bromide by stating 
		that production may not extend beyond, ``a date more that seven years 
		after January 1 of the year after the year in which the substance is added 
		to the list of class I substances.'' With this proposal, EPA is reserving 
		action in allocating potential production allowances for control periods 
		starting with January 1, 2001, and beyond. 
	   III. Legal Authority 
	   EPA believes that it has the authority, under both the Montreal Protocol 
		and Section 604 (e) of the Clean Air Act Amendments of 1990 (CAA) to allow 
		increased production of methyl bromide for export to Article 5 countries 
		for the control periods from 1994 to the end of 2000. The Parties to the 
		Protocol, in the Fourth Meeting in Copenhagen, agreed to list methyl bromide 
		as a class I substance. The CAA requires EPA to phase out any newly-listed 
		substances seven years after January 1 of the year following the year 
		in which the chemical was listed. In following the mandate of the CAA, 
		methyl bromide is phased out in the United States by January 1, 2001. 
		The December 10, 1993 final rule incorporates such a phaseout of methyl 
		bromide and on December 30, 1993, EPA allocated baseline production and 
		consumption allowances for methyl bromide.
		Both the Protocol and the CAA allow persons with baseline production allowances 
		to produce an additional 10 percent for export to Article 5 countries. 
		As discussed earlier, in Article 2H of the Protocol, the Parties agreed 
		to permit continued production of up to 10 percent of baseline levels 
		of controlled substances for export to Article 5 countries. The CAA also 
		authorizes continued production for such purposes. CAA section 604(e) 
		(Developing Countries) states: (1) Exception.--Notwithstanding the phase-out 
		and termination of production required under subsections (a) and (b), 
		the Administrator, after notice and opportunity for public comment may, 
		consistent with the Montreal Protocol, authorize the production of limited 
		quantities of a class I substance in excess of the amounts otherwise allowable 
		under subsection (a) or (b), or both, solely for export to, and use in, 
		developing countries that are Parties to the Montreal Protocol and are 
		operating under article 5 of such Protocol. Any production authorized 
		under this paragraph shall be solely for purposes of satisfying the basic 
		domestic needs of such countries. (2) Cap on Exception.--(A) Under no 
		circumstances may the authority set forth in paragraph (1) be applied 
		to authorize any person to produce a class I substance in any year for 
		which a production percentage is specified in Table 2 of subsection (a) 
		in an annual quantity greater than the specified percentage, plus an amount 
		equal to 10 percent of the amount produced by such person in the baseline 
		year. Section 604(e)(1) authorizes the production of limited quantities 
		of a class I substance in excess of the amounts otherwise allowable ``under 
		subsection (a) or (b).'' In the case of methyl bromide, the production 
		reductions and phaseout schedules listed in subsection (a) and (b) have 
		been modifed according to section 602(d) to require a freeze at 1994 production 
		levels for methyl bromide until January 1, 2001, at which time methyl 
		bromide may no longer be produced. Thus, sections 604(e)(1) & (2), 
		as applied to methyl bromide, authorize additional production equal to 
		1012f 1994 baseline allowances solely for export to Article 5 countries 
		until the year in which methyl bromide is phased out.
		The Clean Air Act Amendments anticipated the need to continue to supply 
		controlled substances to Article 5 countries despite the freeze and the 
		eventual elimination of production and consumption of these chemicals. 
		Section 604(e) allows for this production, provided it is consistent with 
		the Montreal Protocol. Accordingly, EPA allocated potential production 
		allowances for class I substances in the December 10, 1993 final rule. 
		The authority to allocate such allowances applied to the newly-listed 
		methyl bromide. However, due to an oversight, methyl bromide was not included 
		in the list of chemicals for which potential production allowances were 
		granted. 
	   IV. Proposed Production Levels 
	   EPA proposes that companies that produced methyl bromide in 1991 be 
		allowed to produce up to 10 percent of their baseline allowances for Article 
		5 countries for the control periods starting January 1, 1994, and ending 
		before January 1, 2001. EPA is setting the level at 10 percent to be consistent 
		with Article 2H of the Montreal Protocol, and to be consistent with the 
		approach used for all Class I controlled substances except for Group VII, 
		the hydrobromofluorocarbons (no additional production for Article 5 countries 
		is granted under the Protocol for these chemicals).
		Although EPA considered setting the level of additional production at 
		less than 10 percent, EPA believes that a more stringent level would be 
		disadvantageous to U.S. producers, with no added environmental benefit. 
		If U.S. companies were limited to additional production of less than 10 
		percent for export to Article 5 countries, producers from other countries 
		would easily meet the existing demand of Article 5 countries. In other 
		words, the total potential supply that the Protocol allows all developed 
		countries to produce for Article 5 countries is much greater than the 
		demand of all the developing countries that are Parties to the Protocol. 
		Thus, if U.S. companies do not produce the methyl bromide for Article 
		5 countries, another Party will. Since the same amount of methyl bromide 
		will be consumed by the developing countries, whether the U.S. or another 
		Party produces it, a U.S. reduction in the percent of additional production 
		would have no environmental impact.
		EPA believes it is important that the network of United States exports 
		of methyl bromide be maintained in order to continue market contacts. 
		EPA presumes that United States producers will be leaders in developing 
		alternative pesticides to methyl bromide. EPA believes that it is U.S. 
		producers of methyl bromide who will quickly develop alternative pesticide 
		practices, and therefore provide Article 5 countries with the alternatives 
		necessary to eliminate the use of this controlled substance. The current 
		international sales networks of U.S. methyl bromide producers will serve 
		as a conduit for disseminating to Article 5 countries alternatives to 
		methyl bromide once they are developed.
		In today's rule, EPA clarifies that under the current regulations, the 
		production allowances for Article 5 countries may be retroactive to the 
		beginning of the control period starting January 1, 1994. The current 
		regulations refer to control periods and do not prohibit companies from 
		seeking authorizations for potential production allowances already exported, 
		as long as that export occurred and the potential production allowance 
		is used in the same control period. 
	   V. Summary of Supporting Analysis 
	   A. Executive Order 12866 
	   Under Executive Order 12866 (58 FR 51735, October 4, 1993), the Agency 
		must determine whether this regulatory action is ``significant'' and therefore 
		subject to OMB review and the requirements of the Executive Order. The 
		Order defines ``significant'' regulatory action as one that is likely 
		to lead to a rule that may: 
	   (1) Have an annual effect on the economy of $100 million or more, or 
		adversely and materially affect a sector of the economy, productivity, 
		competition, jobs, the environment, public health or safety, or State, 
		local, or tribal governments or communities; (2) Create a serious inconsistency 
		or otherwise interfere with an action taken or planned by another agency; 
		(3) Materially alter the budgetary impact of entitlement, grants, user 
		fees, or loan programs or the rights and obligations of recipients thereof; 
		or
		(4) Raise novel legal or policy issues arising out of legal mandates, 
		the President's priorities, or the principles set forth in the Executive 
		Order. 
	   It has been determined by OMB and EPA that this amendment to the final 
		rule is not a ``significant regulatory action'' under the terms of Executive 
		Order 12866 and is therefore not subject to OMB review under the Executive 
		Order. 
	   B. Regulatory Flexibility Act 
	   The Regulatory Flexibility Act, 5 U.S.C. 601-602, requires that Federal 
		agencies examine the impacts of their regulations on small entities. Under 
		5 U.S.C. 604(a), whenever an agency is required to publish a general notice 
		of proposed rulemaking, it must prepare and make available for public 
		comment an initial regulatory flexibility analysis (RFA). Such an analysis 
		is not required if the head of an agency certifies that a rule will not 
		have a significant economic impact on a substantial number of small entities, 
		pursuant to 5 U.S.C. 605(b).
		EPA believes that any impact that this amendment will have on the regulated 
		community will serve only to provide relief from otherwise applicable 
		regulations, and will therefore limit the negative economic impact associated 
		with the regulations previously promulgated under sections 604 and 606. 
		An examination of the impacts on small entities was discussed in the final 
		rule (58 FR 65018 and 58 FR 69235). That final rule assessed the impact 
		the rule may have on small entities. A separate regulatory impact analysis 
		accompanied the final rule and is contained in Docket A-92-01. I certify 
		that this amendment to the accelerated phaseout rule will not have any 
		additional negative economic impacts on any small entities. 
	   C. Paperwork Reduction Act 
	   Any information collection requirements in a rule must be submitted 
		for approval to the Office of Management and Budget (OMB) under the Paperwork 
		Reduction Act, 44 U.S.C. 3501 et seq. Because no additional informational 
		collection requirements are required by this amendment, EPA has determined 
		that the Paperwork Reduction Act does not apply to this rulemaking and 
		no new Information Collection Request document has been prepared. 
	   List of Subjects in 40 CFR Part 82 
	   Environmental protection, Administrative practice and procedure, Air 
		pollution control, Chemicals, Chlorofluorocarbons, Exports, Hydrochlorofluorocarbons, 
		Imports, Interstate commerce, Nonessential products, Reporting and recordkeeping 
		requirements, Stratospheric ozone layer. 
	   Dated: September 30, 1994.
		Carol M. Browner,
		Administrator. 
	   40 CFR part 82 is proposed to be amended as follows: 
	   PART 82--PROTECTION OF STRATOSPHERIC OZONE 
	  
		
  • The authority citation for part 82 continues to read as follows: Authority: 42 U.S.C. 7414, 7671-671q. Subpart A--Production and Consumption Controls 2. Section 82.9 is amended by revising paragraphs (a) introductory text, and (a)(1) and (a)(2) to read as follows: Sec. 82.9 Availability of production allowances in addition to baseline production allowances. (a) Every person apportioned baseline production allowances for class I controlled substances under Sec. 82.5 (a) through (f) is granted potential production allowances equal to: (1) 10 percent of his apportionment under Sec. 82.5 for each control period ending before January 1, 2000 (January 1, 2001 for methyl bromide); and (2) 15 percent of his apportionment under Sec. 82.5 for each control period beginning after December 31, 1999, and ending before January 1, 2011 (January 1, 2013 in the case of methyl chloroform; except for methyl bromide which is reserved). [FR Doc. 94-25200 Filed 10-13-94; 8:45 am] BILLING CODE 6560-50-P
  •  
     


    Local Navigation


    Jump to main content.